Summary of Canon Medical Systems’ Innovations – RSNA 2025
This text details two key innovations from Canon Medical Systems presented at RSNA 2025: the Aquilion Rise® and the PCCT photon counting scanner.
Aquilion Rise®:
* Focus: Improved patient accessibility and comfort, especially for those with mobility issues.
* Key Features:
* Allows scanning in standing or other non-lying positions.
* Suitable for a wide range of imaging needs: musculoskeletal, prolapse/gravity-affected pathologies, functional pathologies, and dynamic/vascular studies.
* Integrates Canon’s existing AI-powered image reconstruction technology for improved image quality and dose control.
* Designed for personalized imaging, adapting to patient morphology, posture, and physiology.
* Status: Class IIb medical device,undergoing CE marking for European market availability.
PCCT Photon Counting Scanner:
* Focus: Next-generation CT imaging with higher resolution, lower radiation dose, and advanced spectral capabilities.
* Key Features:
* Photon Counting: Individually measures the energy of X-rays, enabling native spectral sensitivity for better tissue characterization and quantification.
* Ultra-High Resolution: Builds on Canon’s existing UHR technology (Aquilion Precision®).
* Reduced Radiation Dose: Substantially lowers X-ray exposure.
* advanced Spectral Applications: Potential to transform diagnosis and patient care.
* Technology: Utilizes a Zinc-doped CZT (Cadmium Zinc Telluride) detector for improved sensitivity and energy resolution. Canon acquired Redlen Technologies to bolster detector advancement.
* Status: Ongoing international clinical research and pilot installations to validate diagnostic effectiveness.
In essence, Canon Medical Systems is pushing the boundaries of CT imaging with innovations focused on both patient experience and diagnostic capabilities. The Aquilion Rise® addresses accessibility, while the PCCT scanner represents a significant leap forward in image quality, dose reduction, and spectral imaging.